Peptron, Inc. (KOSDAQ:087010)
92,000
+200 (0.22%)
Mar 31, 2025, 3:30 PM KST
Peptron Revenue
In the year 2024, Peptron had annual revenue of 3.15B KRW, down -5.68%. Peptron had revenue of 1.54B in the quarter ending December 31, 2024, with 93.16% growth.
Revenue
3.15B
Revenue Growth
-5.68%
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
n/a
Market Cap
2,143.36B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.15B | -189.71M | -5.68% |
Dec 31, 2023 | 3.34B | -2.47B | -42.52% |
Dec 31, 2022 | 5.81B | -810.52M | -12.24% |
Dec 31, 2021 | 6.62B | 3.50B | 112.28% |
Dec 31, 2020 | 3.12B | 1.32B | 73.26% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
SK Biopharmaceuticals | 547.60B |
HLB Co., Ltd. | 51.92B |
Sam Chun Dang Pharm. | 210.92B |
PharmaResearch | 350.12B |